Susceptibility pathways in Fanconi's anemia and breast cancer.
D'Andrea
Alan D
AD
Department of Radiation Oncology, Dana-Farber Cancer Institute, Children's Hospital, and Harvard Medical School, Boston, MA 02115, USA. alan_dandrea@dfci.harvard.edu
D001943:Breast Neoplasms / Q000235:genetics*; D019175:DNA Methylation; D004260:DNA Repair / Q000502:physiology*; D044127:Epigenesis, Genetic; D005199:Fanconi Anemia / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D051856:Fanconi Anemia Complementation Group Proteins / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D005260:Female; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation; D006801:Humans; D053858:Metabolic Networks and Pathways; D009154:Mutation; D010051:Ovarian Neoplasms / Q000235:genetics
D051856:Fanconi Anemia Complementation Group Proteins